Background The evidence base for the treatment of mild obstructive sleep apnoea is limited
and definitions of disease severity vary. The MERGE trial investigated the clinical …

Background The therapeutic and economic benefits of continuous positive airway pressure
(CPAP) for moderate to severe obstructive sleep apnoea (OSA) syndrome have been …

Background: Obstructive sleep apnoea syndrome (OSAS) affects an estimated 2–4% of the
middle aged population. Meta-analyses of randomised controlled trials have shown that the …

Rationale: Twenty-eight percent of people with mild to moderate obstructive sleep apnea
experience daytime sleepiness, which interferes with daily functioning. It remains unclear …

BACKGROUND The therapeutic and economic benefits of continuous positive airway
pressure (CPAP) for the treatment of obstructive sleep apnoea syndrome (OSAS) have been …

Background Nasal continuous positive airway pressure (NCPAP) is widely used as a
treatment for obstructive sleep apnoea. However, to date there are no randomised controlled …

Background: It is unclear whether continuous positive airway pressure (CPAP), the treatment
of choice for severe obstructive sleep apnoea (OSA), is effective at improving outcomes in …

Background Obstructive sleep apnea is a relatively common disorder that can lead to lost
productivity and cardiovascular disease. The form of positive airway treatment that should be …

Background Continuous Positive Airways Pressure (CPAP) is currently considered to be the
cornerstone of therapy for sleep apnoea (OSA). However compliance with this treatment is …

Continuous positive airway pressure (CPAP) is the standard treatment for obstructive sleep
apnea syndrome (OSAS). However, the impact of CPAP on quality of life (QOL) is …